MedPath

ENDOCRINOLOGY LABORATORY

ENDOCRINOLOGY LABORATORY logo
🇺🇸United States
Ownership
Private
Established
1964-01-01
Employees
1K
Market Cap
-
Website
http://www.evms.edu

Clinical Trials

54

Active:0
Completed:25

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:5
Phase 2:6
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Not Applicable
20 (44.4%)
Phase 4
9 (20.0%)
Phase 2
6 (13.3%)
Phase 1
5 (11.1%)
Phase 3
4 (8.9%)
Early Phase 1
1 (2.2%)

Lactated Ringer's and Dextrose 5% vs Only Lactated Ringer's in Labor

Not Applicable
Recruiting
Conditions
Induced Labor
Interventions
Drug: 5% Dextrose (D5) in Normal Saline (NS)
Drug: Lactate Ringer
First Posted Date
2025-08-15
Last Posted Date
2025-08-22
Lead Sponsor
Eastern Virginia Medical School
Target Recruit Count
158
Registration Number
NCT07124130
Locations
🇺🇸

Sentara Norfolk General Hospital, Norfolk, Virginia, United States

🇮🇹

Policlinico di Modena, Modena, Italy

Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM

Not Applicable
Recruiting
Conditions
Preterm PROM (Pregnancy)
Interventions
Combination Product: Oxytocin plus Foley Catheter
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Eastern Virginia Medical School
Target Recruit Count
80
Registration Number
NCT07119398
Locations
🇺🇸

Sentara Norfolk General Hospital, Norfolk, Virginia, United States

Effectiveness of Smartphone Application for Adherence Support (Vuka+)

Not Applicable
Completed
Conditions
Adherence, Medication
Smartphone Application
First Posted Date
2025-03-26
Last Posted Date
2025-03-26
Lead Sponsor
Eastern Virginia Medical School
Target Recruit Count
330
Registration Number
NCT06897059
Locations
🇿🇦

Desmond Tutu Health Foundation, Cape Town, South Africa

Effect of Fiber Supplementation on the Need for Medication with Gestational Diabetes

Not Applicable
Recruiting
Conditions
Gestational Diabetes Mellitus (GDM)
First Posted Date
2025-03-10
Last Posted Date
2025-03-10
Lead Sponsor
Eastern Virginia Medical School
Target Recruit Count
110
Registration Number
NCT06867861
Locations
🇺🇸

Macon & Joan Brock Virginia Health Sciences at ODU, Norfolk, Virginia, United States

VR for Lac Repairs in Peds Emergency Department

Not Applicable
Completed
Conditions
Laceration
First Posted Date
2024-07-23
Last Posted Date
2024-07-23
Lead Sponsor
Eastern Virginia Medical School
Target Recruit Count
91
Registration Number
NCT06516003
Locations
🇺🇸

Children's Hospital of the King's Daughters, Norfolk, Virginia, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

News

Tezepelumab Shows Remarkable 92% Reduction in Nasal Polyp Surgery Need in Phase 3 Trial

Phase 3 WAYPOINT trial demonstrates tezepelumab significantly reduced nasal polyp severity and improved nasal congestion scores in patients with severe chronic rhinosinusitis with nasal polyps.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.